首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1819731

2021-2031年亚太地区解剖病理学市场报告（范围、细分、动态和竞争分析）

Asia Pacific Anatomic Pathology Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

出版日期: 2025年07月10日 | 出版商:

The Insight Partners | 英文 135 Pages | 订单完成后即时交付

价格

简介目录图表

解剖病理学市场预计将大幅成长，到 2031 年将达到 140.3208 亿美元，高于 2023 年的 72.5284 亿美元。这一成长代表着 2023 年至 2031 年的年复合成长率(CAGR) 为 8.6%。

执行摘要和亚太解剖病理学市场概览

在亚太地区，解剖病理学市场的主要参与者包括中国、日本、印度、澳洲和韩国，并对该地区其他国家进行了深入分析。该地区解剖病理学市场的成长主要得益于慢性病盛行率的上升以及数位化解决方案和先进病理学工具的普及。澳洲和韩国等国家由于其医疗保健系统的不断发展，预计将带来巨大的成长机会。

市场区隔分析

亚太地区解剖病理学市场可以根据产品和服务、应用和最终用户进行细分。

1. 产品和服务：此部分包括服务、仪器和耗材。 2023年，仪器占据了最大的市场。服务部分进一步细分为组织病理学和细胞病理学，而仪器部分包括切片机、低温恆温器、自动染色机、组织处理机和其他相关工具。

2. 应用：市场分为疾病诊断、药物发现及开发等。疾病诊断领域在2023年占据最大份额，反映了解剖病理学在识别各种健康状况方面的关键作用。

3. 最终使用者：此部分包括医院、研究实验室、诊断实验室等。医院在2023年占据了最大的市场份额，凸显了其在利用解剖病理学服务方面的核心作用。

亚太解剖病理学市场展望

数位病理学是解剖病理学领域的一个新兴领域，它利用数位技术来增强资料收集和管理流程。这项创新最大限度地降低了标本处理的风险，并有可能加快临床试验的患者入组速度。此外，数位病理学可以显着缩短从样本采集到结果的周转时间，从而简化中央病理学审查流程，提高试验效率。

机器学习 (ML) 和人工智慧 (AI) 与数位病理学的融合，正在透过增强资料分析和管理能力，彻底改变该领域。许多解剖病理学实验室越来越认识到数位化和人工智慧的优势，它们有望提高诊断的准确性、效率和一致性。近期的技术进步和监管审批正在进一步推动实验室营运的数位化。

2023年11月，Dedalus Group 和 Ibex Medical Analytics 推出了一个基于人工智慧的全面数位病理学解决方案，旨在用于癌症诊断。该解决方案透过下一代解剖病理学资讯系统 (AIS) 和数位病理学解决方案，促进解剖病理学实验室的全面数位化，利用资料和人工智慧来改善病例优先排序、进阶影像分析和一致性诊断。解剖病理学流程中对人工智慧整合的日益重视，预计将成为未来几年推动市场成长的重要趋势。

亚太解剖病理学市场的国家洞察

亚太解剖病理学市场涵盖中国、日本、印度、澳洲、韩国等国。 2023年，中国占最大市场份额。癌症已成为中国的主要公共卫生问题。世界卫生组织 (WHO) 报告称，2020年中国新增癌症病例457万例，癌症相关死亡人数300万例，均为全球最高。这一令人担忧的趋势促使人们更加重视早期癌症筛检、诊断和治疗。

近二十年来，中国政府实施了「农村癌症筛检计画」、「农村妇女子宫颈癌和乳癌筛检计画」等多项大规模癌症筛检计划，显着提高了全民各类癌症的筛检率，为基层医疗卫生机构做好癌症防治工作做出了贡献。

此外，中国正在从传统的病理诊断方法转型为数位病理学。根据上海数位医学创新中心2022年的报告，约40%的受访医院正在开发或已经建立了数位病理系统。许多医院已在这些系统上投入了大量资金，显示其致力于提升诊断能力。报告也指出，2022年约有23%的远距临床会诊使用了数位病理学，反映出其在医疗保健领域日益增长的重要性。

亚太解剖病理学市场的关键参与者

解剖病理学市场的知名公司包括罗氏公司 (F. Hoffmann-La Roche Ltd)、贝克曼库尔特公司 (Beckman Coulter Inc)、豪洛捷公司 (Hologic Inc)、安捷伦科技公司 (Agilent Technologies Inc)、BioGenex Laboratories Inc、Diapath SpA、Bio SB、默克公司 (Merck KGaA Holdings) 和 PHCK Holdings) 等。这些公司正在采取各种策略，包括扩张、产品创新和併购，以增强其产品线并提升其市场占有率。

In the Asia Pacific region, key players in the anatomic pathology market include China, Japan, India, Australia, and South Korea, with additional insights into other countries in the area. The growth of the anatomic pathology market in this region is primarily driven by the increasing prevalence of chronic diseases and the adoption of digital solutions and advanced pathology tools. Countries like Australia and South Korea are expected to present substantial growth opportunities due to their continuously evolving healthcare systems.

Market Segmentation Analysis

The Asia Pacific anatomic pathology market can be segmented based on products and services, applications, and end users.

1. Products and Services: This segment includes services, instruments, and consumables. In 2023, instruments accounted for the largest market share. The services segment is further divided into histopathology and cytopathology, while the instruments segment includes microtomes, cryostats, automatic stainers, tissue processors, and other related tools.

2. Applications: The market is categorized into disease diagnosis, drug discovery and development, among others. The disease diagnosis segment held the largest share in 2023, reflecting the critical role of anatomic pathology in identifying various health conditions.

3. End Users: This segment includes hospitals, research laboratories, diagnostic laboratories, and others. Hospitals represented the largest share of the market in 2023, highlighting their central role in utilizing anatomic pathology services.

Market Outlook for Asia Pacific Anatomic Pathology

Digital pathology is an emerging area within anatomic pathology that leverages digital technologies to enhance data collection and management processes. This innovation minimizes risks associated with specimen handling and has the potential to expedite patient enrollment in clinical trials. Furthermore, digital pathology can significantly reduce the turnaround time from sample collection to results, thereby streamlining the central pathology review process and improving trial efficiency.

The integration of machine learning (ML) and artificial intelligence (AI) into digital pathology is transforming the field by enhancing data analysis and management capabilities. Many anatomic pathology laboratories are increasingly recognizing the advantages of digitization and AI, which are expected to improve diagnostic accuracy, efficiency, and consistency. Recent technological advancements and regulatory approvals are further promoting the digitalization of laboratory operations.

In November 2023, Dedalus Group and Ibex Medical Analytics introduced a comprehensive AI-powered Digital Pathology Solution aimed at cancer diagnostics. This solution facilitates the complete digitization of anatomic pathology laboratories through a next-generation Anatomic Pathology Information System (AIS) and digital pathology solution, utilizing data and AI for improved case prioritization, advanced image analysis, and consistent diagnoses. The growing emphasis on AI integration in anatomic pathology processes is anticipated to be a significant trend that will drive market growth in the coming years.

Country Insights in the Asia Pacific Anatomic Pathology Market

The Asia Pacific anatomic pathology market includes countries such as China, Japan, India, Australia, South Korea, and others. In 2023, China held the largest market share. Cancer has become a major public health issue in China, with the World Health Organization (WHO) reporting 4.57 million new cancer cases and 3.00 million cancer-related deaths in 2020, the highest globally. This alarming trend has led to a heightened focus on early cancer screening, diagnosis, and treatment.

Over the past two decades, the Chinese government has implemented several large-scale cancer screening initiatives, such as the "Cancer Screening Program in Rural Areas" and the "Cervical Cancer and Breast Cancer Screening Program for Women in Rural Areas." These programs have significantly increased the rate of population-wide screenings for various cancers, contributing to better cancer prevention and control at primary healthcare facilities.

Moreover, China is transitioning from traditional pathological diagnosis methods to digital pathology. According to a 2022 report by the Shanghai Digital Medicine Innovation Center, approximately 40% of surveyed hospitals are either developing or have already established digital pathology systems. Many of these hospitals have invested substantial amounts in these systems, indicating a strong commitment to enhancing their diagnostic capabilities. The report also noted that around 23% of remote clinical consultations utilized digital pathology in 2022, reflecting its growing importance in the healthcare landscape.

Key Players in the Asia Pacific Anatomic Pathology Market

Prominent companies in the anatomic pathology market include F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, BioGenex Laboratories Inc, Diapath S.p.A., Bio SB, Merck KGaA, and PHC Holdings Corporation, among others. These companies are pursuing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their offerings and increase their market presence.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Asia Pacific Anatomic Pathology Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Asia Pacific Anatomic Pathology Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increase in Prevalence of Cancer and Kidney Diseases
- 5.1.2 Rise in Number of Strategic Initiatives
5.2 Market Restraints
- 5.2.1 Lack of Skilled Professionals
- 5.2.2 Stringent Government Regulations
5.3 Market Opportunities
- 5.3.1 Growing Focus on Personalized Medicines
5.4 Future Trends
- 5.4.1 Integration of Artificial Intelligence and Machine Learning
5.5 Impact of Drivers and Restraints:

6. Anatomic Pathology Market - Asia Pacific Analysis

6.1 Asia Pacific Anatomic Pathology Market Revenue (US$ Million), 2021-2031
6.2 Asia Pacific Anatomic Pathology Market Forecast Analysis

7. Asia Pacific Anatomic Pathology Market Analysis - by Product and Services

7.1 Services
- 7.1.1 Overview
- 7.1.2 Services: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Consumables
- 7.3.1 Overview
- 7.3.2 Consumables: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Anatomic Pathology Market Analysis - by Application

8.1 Disease Diagnosis
- 8.1.1 Overview
- 8.1.2 Disease Diagnosis: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Drug Discovery and Development
- 8.2.1 Overview
- 8.2.2 Drug Discovery and Development: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Anatomic Pathology Market Analysis - by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Research Laboratories
- 9.2.1 Overview
- 9.2.2 Research Laboratories: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Diagnostic Laboratories
- 9.3.1 Overview
- 9.3.2 Diagnostic Laboratories: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

10. Asia Pacific Anatomic Pathology Market - Country Analysis

10.1 Asia Pacific
- 10.1.1 Asia Pacific Anatomic Pathology Market Overview
- 10.1.2 Asia Pacific Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
  - 10.1.2.1 China: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.1.1 China: Asia Pacific Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.1.1.1 China: Asia Pacific Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.1.1.2 China: Asia Pacific Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.1.2 China: Asia Pacific Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.1.3 China: Asia Pacific Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.2 Japan: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.2.1 Japan: Asia Pacific Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.2.1.1 Japan: Asia Pacific Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.2.1.2 Japan: Asia Pacific Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.2.2 Japan: Asia Pacific Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.2.3 Japan: Asia Pacific Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.3 India: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.3.1 India: Asia Pacific Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.3.1.1 India: Asia Pacific Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.3.1.2 India: Asia Pacific Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.3.2 India: Asia Pacific Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.3.3 India: Asia Pacific Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.4 Australia: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.4.1 Australia: Asia Pacific Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.4.1.1 Australia: Asia Pacific Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.4.1.2 Australia: Asia Pacific Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.4.2 Australia: Asia Pacific Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.4.3 Australia: Asia Pacific Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.5 South Korea: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.5.1 South Korea: Asia Pacific Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.5.1.1 South Korea: Asia Pacific Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.5.1.2 South Korea: Asia Pacific Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.5.2 South Korea: Asia Pacific Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.5.3 South Korea: Asia Pacific Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.6 Rest of APAC: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.6.1 Rest of APAC: Asia Pacific Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.6.1.1 Rest of APAC: Asia Pacific Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.6.1.2 Rest of APAC: Asia Pacific Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.6.2 Rest of APAC: Asia Pacific Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.6.3 Rest of APAC: Asia Pacific Anatomic Pathology Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Asia Pacific Anatomic Pathology Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 F. Hoffmann-La Roche Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Beckman Coulter Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Hologic Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Agilent Technologies Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 BioGenex Laboratories Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Diapath S.p.A.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Bio SB
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Merck KGaA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 PHC Holdings Corporation
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Asia Pacific Anatomic Pathology Market Segmentation
Table 2. Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by Product and Services
Table 4. Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 5. Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 6. China: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 7. China: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 8. China: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 9. China: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 10. China: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 11. Japan: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 12. Japan: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 13. Japan: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 14. Japan: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 15. Japan: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 16. India: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 17. India: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 18. India: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 19. India: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 20. India: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 21. Australia: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 22. Australia: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 23. Australia: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 24. Australia: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 25. Australia: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 26. South Korea: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 27. South Korea: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 28. South Korea: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 29. South Korea: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 30. South Korea: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 31. Rest of APAC: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 32. Rest of APAC: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 33. Rest of APAC: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 34. Rest of APAC: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 35. Rest of APAC: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 36. Recent Organic Growth Strategies in Asia Pacific Anatomic Pathology Market
Table 37. Recent Inorganic Growth Strategies in the Asia Pacific Anatomic Pathology Market
Table 38. Glossary of Terms, Asia Pacific Anatomic Pathology Market

List Of Figures

Figure 1. Asia Pacific Anatomic Pathology Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Asia Pacific Anatomic Pathology Market - Key Market Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Asia Pacific Anatomic Pathology Market Revenue (US$ Million), 2021-2031
Figure 6. Asia Pacific Anatomic Pathology Market Share (%) - by Product and Services (2023 and 2031)
Figure 7. Services: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Instruments: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Consumables: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Asia Pacific Anatomic Pathology Market Share (%) - by Application (2023 and 2031)
Figure 11. Disease Diagnosis: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Drug Discovery and Development: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Others: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Asia Pacific Anatomic Pathology Market Share (%) - by End User (2023 and 2031)
Figure 15. Hospitals: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Research Laboratories: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Diagnostic Laboratories: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Others: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Asia Pacific Anatomic Pathology Market Breakdown, by Key Countries - Revenue (2023) (US$ Million)
Figure 20. Asia Pacific Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 21. China: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 22. Japan: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 23. India: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 24. Australia: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 25. South Korea: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 26. Rest of APAC: Asia Pacific Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 27. Growth Strategies in Asia Pacific Anatomic Pathology Market